Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Claud B who wrote (3028)	3/25/1998 7:30:00 PM
From: Bill Wexler	Read Replies (3) \| Respond to of 7041

Zona tries to mislead investors again. Zona issued a press release today which seems to imply that they received a patent for their "original" formulation of Vasomax. What really happened is that they bought the rights to another obscure patent filed in 1995 by Fred Lowrey. I'm still trying to track down the text of the patent. I would appreciate any help.

To: Claud B who wrote (3028)	3/25/1998 8:07:00 PM
From: Tokyo VD	Read Replies (1) \| Respond to of 7041

Claud, Your last post was unclear. If the Company far exceeded the number of patients in trials for 1 year, then why did they lead everyone to believe that they had enough data as of June, 1997? Was the Company being promotional when they established this date? (What I am really asking you is when did the Company achieve the appropriate number of patients to proceed with an NDA filing?) Tokyo